Adaptimmune Therapeutics plc ADAP
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 0.54 | 103.83 | -0.05 | -73,519 | -74 | |
| 2024Q3 | 0.95 | 93.64 | -0.01 | -14,680 | -18 | |
| 2024Q2 | 0.97 | 97.35 | 0.04 | 68,700 | 70 | |
| 2024Q1 | 1.58 | 102.68 | -0.03 | -49,261 | -49 | |
| 2023Q4 | 0.79 | 102.64 | -0.03 | -49,856 | -48 | |
| 2023Q3 | 0.78 | 103.83 | -0.04 | -46,633 | -46 | |
| 2023Q2 | 0.93 | 216.85 | -0.02 | -44,908 | -21 | |
| 2023Q1 | 1.09 | 99.70 | 0.00 | 1,656 | 1 | |
| 2022Q4 | 1.46 | 96.41 | -0.03 | -27,242 | -29 | |
| 2022Q3 | 1.08 | 104.80 | -0.04 | -42,990 | -41 | |
| 2022Q2 | 1.70 | 99.32 | -0.05 | -43,752 | -45 | |
| 2022Q1 | 2.06 | 100.71 | -0.05 | -49,981 | -50 | |
| 2021Q4 | 3.75 | 110.91 | -0.04 | -42,864 | -39 | |
| 2021Q3 | 5.17 | 99.97 | -0.05 | -42,181 | -42 | |
| 2021Q2 | 4.26 | 100.82 | -0.04 | -39,312 | -39 | |
| 2021Q1 | 5.31 | 101.13 | -0.04 | -37,889 | -38 | |
| 2020Q4 | 5.39 | 102.60 | -0.04 | -37,513 | -37 | |
| 2020Q3 | 7.98 | 101.29 | -0.04 | -35,875 | -35 | |
| 2020Q2 | 10.01 | 101.33 | -0.03 | -30,253 | -30 | |
| 2020Q1 | 2.72 | 105.93 | -0.04 | -29,764 | -28 |